This study is in progress, not accepting new patients
Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pliant Therapeutics, Inc.
- ID
- NCT04480840
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 112 study participants
- Last Updated